IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 92
Titolo Data di pubblicazione Autore(i) File
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 1-gen-2009 DE LUCA, Laura; Ferro, Stefania; Agnello, Stefano; Gitto, Rosaria; Monforte, Anna Maria; Iraci, Nunzio; Barreca, Ml; Debyser, Z; Chimirri, Alba
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 1-gen-2009 Ferro, Stefania; DE LUCA, Laura; Barreca, Maria Letizia; Iraci, Nunzio; DE GRAZIA, Sara; Christ, F; Witvrouw, M; Debyser, Z; Chimirri, Alba
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: A basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy 1-gen-2010 Lewis, M. G.; Norelli, S.; Collins, M.; Barreca, M. L.; Iraci, N.; Chirullo, B.; Yalley-Ogunro, J.; Greenhouse, J.; Titti, F.; Garaci, E.; Savarino, A.
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors 1-gen-2010 Monforte, Anna Maria; Logoteta, Patrizia; De Luca, Laura; Iraci, N.; Ferro, Stefania; Maga, G.; De Clercq, E.; Pannecouque, C.; Chimirri, Alba
Allosteric inhibition of the hepatitis C virus NS5B polymerase: In silico strategies for drug discovery and development 1-gen-2011 Barreca, M. L.; Iraci, N.; Manfroni, G.; Cecchetti, V.
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model 1-gen-2012 Shytaj, I. L.; Norelli, S.; Chirullo, B.; Della Corte, A.; Collins, M.; Yalley-Ogunro, J.; Greenhouse, J.; Iraci, N.; Acosta, E. P.; Barreca, M. L.; Lewis, M. G.; Savarino, A.
Pyrazolo[4,3-c ][1,2]benzothiazines 5,5-dioxide: A promising new class of staphylococcus aureus NorA efflux pump inhibitors 1-gen-2012 Sabatini, S.; Gosetto, F.; Serritella, S.; Manfroni, G.; Tabarrini, O.; Iraci, N.; Brincat, J. P.; Carosati, E.; Villarini, M.; Kaatz, G. W.; Cecchetti, V.
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 1-gen-2012 Manfroni, G.; Meschini, F.; Barreca, M. L.; Leyssen, P.; Samuele, A.; Iraci, N.; Sabatini, S.; Massari, S.; Maga, G.; Neyts, J.; Cecchetti, V.
Re-evolution of the 2-phenylquinolines: Ligand-based design, synthesis, and biological evaluation of a potent new class of staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance 1-gen-2013 Sabatini, S.; Gosetto, F.; Iraci, N.; Barreca, M. L.; Massari, S.; Sancineto, L.; Manfroni, G.; Tabarrini, O.; Dimovska, M.; Kaatz, G. W.; Cecchetti, V.
Structure-based discovery of pyrazolobenzothiazine derivatives as inhibitors of hepatitis C virus replication 1-gen-2013 Barreca, M. L.; Manfroni, G.; Leyssen, P.; Winquist, J.; Kaushik-Basu, N.; Paeshuyse, J.; Krishnan, R.; Iraci, N.; Sabatini, S.; Tabarrini, O.; Basu, A.; Danielson, U. H.; Neyts, J.; Cecchetti, V.
From small to powerful: The fragments universe and its 'chem-appeal' 1-gen-2013 Sancineto, L.; Massari, S.; Iraci, N.; Tabarrini, O.
Computer-aided design, synthesis and validation of 2-phenylquinazolinone fragments as CDK9 inhibitors with anti-HIV-1 tat-mediated transcription activity 1-gen-2013 Sancineto, L.; Iraci, N.; Massari, S.; Attanasio, V.; Corazza, G.; Barreca, M. L.; Sabatini, S.; Manfroni, G.; Avanzi, N. R.; Cecchetti, V.; Pannecouque, C.; Marcello, A.; Tabarrini, O.
New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site i inhibitors 1-gen-2014 Manfroni, G.; Manvar, D.; Barreca, M. L.; Kaushik-Basu, N.; Leyssen, P.; Paeshuyse, J.; Cannalire, R.; Iraci, N.; Basu, A.; Chudaev, M.; Zamperini, C.; Dreassi, E.; Sabatini, S.; Tabarrini, O.; Neyts, J.; Cecchetti, V.
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B palm site i inhibitors case study 1-gen-2014 Barreca, M. L.; Iraci, N.; Manfroni, G.; Gaetani, R.; Guercini, C.; Sabatini, S.; Tabarrini, O.; Cecchetti, V.
The Versatile Nature of the 6-Aminoquinolone Scaffold: Identification of Submicromolar Hepatitis C Virus NS5B Inhibitors 1-gen-2014 Manfroni, G.; Cannalire, R.; Barreca, M. L.; Kaushik-Basu, N.; Leyssen, P.; Winquist, J.; Iraci, N.; Manvar, D.; Paeshuyse, J.; Guhamazumder, R.; Basu, A.; Sabatini, S.; Tabarrini, O.; Danielson, U. H.; Neyts, J.; Cecchetti, V.
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 1-gen-2014 Sancineto, L.; Iraci, N.; Barreca, M. L.; Massari, S.; Manfroni, G.; Corazza, G.; Cecchetti, V.; Marcello, A.; Daelemans, D.; Pannecouque, C.; Tabarrini, O.
IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes 1-gen-2014 Sgarbanti, M.; Marsili, G.; Remoli, A. L.; Stellacci, E.; Mai, A.; Rotili, D.; Perrotti, E.; Acchioni, C.; Orsatti, R.; Iraci, N.; Ferrari, M.; Borsetti, A.; Hiscott, J.; Battistini, A.
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 1-gen-2015 Sancineto, L.; Mariotti, A.; Bagnoli, L.; Marini, F.; Desantis, J.; Iraci, N.; Santi, C.; Pannecouque, C.; Tabarrini, O.
P38α MAPK and Type I inhibitors: Binding site analysis and use of target ensembles in virtual screening 1-gen-2015 Astolfi, A.; Iraci, N.; Sabatini, S.; Barreca, M. L.; Cecchetti, V.
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 1-gen-2015 Astolfi, A.; Iraci, N.; Manfroni, G.; Barreca, M. L.; Cecchetti, V.
Mostrati risultati da 41 a 60 di 92
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile